Yuan Zhi
Stock Analyst at B. Riley Securities
(3.14)
# 1,671
Out of 4,479 analysts
15
Total ratings
45.45%
Success rate
4.38%
Average return
Main Sectors:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.82 | +265.05% | 1 | May 15, 2024 | |
| CYRX Cryoport | Downgrades: Neutral | $22 → $19 | $6.18 | +207.44% | 3 | May 3, 2024 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $17 | $10.49 | +62.06% | 2 | Apr 9, 2024 | |
| AGEN Agenus | Maintains: Buy | $120 → $100 | $14.28 | +600.28% | 1 | Mar 18, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $51.53 | +53.31% | 3 | Feb 1, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $16 | $6.96 | +129.89% | 4 | Dec 11, 2023 | |
| TNGX Tango Therapeutics | Initiates: Buy | $16 | $8.11 | +97.41% | 1 | Dec 8, 2023 |
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.82
Upside: +265.05%
Cryoport
May 3, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $6.18
Upside: +207.44%
Perspective Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.49
Upside: +62.06%
Agenus
Mar 18, 2024
Maintains: Buy
Price Target: $120 → $100
Current: $14.28
Upside: +600.28%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $51.53
Upside: +53.31%
Actinium Pharmaceuticals
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $6.96
Upside: +129.89%
Tango Therapeutics
Dec 8, 2023
Initiates: Buy
Price Target: $16
Current: $8.11
Upside: +97.41%